Sbir phase I: a new approach for isolating leukocyte sub-populations to enable efficient manufacturing of cellular therapies

Ended Project Grant Awarded Last action

Award ID
1843623
Recipient
Awarding agency
Obligated
$225,000

Award facts

Assistance listing
47.041 Engineering
Completion date
Place of performance
Houston, TX 77204, USA

Award details come from USAspending.gov.

Quick answers

Who received award 1843623?

1843623 was awarded to Halcyon Biomedical Inc. by Division of Industrial Innovation (National Science Foundation) on February 1, 2019.

How much is award 1843623 worth?

$225,000 has been obligated on 1843623.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award